Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: Q
2012 / 04
Your search is limited to one month, search the whole site for Q.
PHARMAC documents that matched your search:
2012-02 PTAC Minutes
(26 pages, 168 KB)
2012/04/20
“Q max and long term safety in the open label phase. The Committee noted that”
PTAC meeting held 16 & 17 February 2012 (minutes for web publishing) PTAC minutes are published in accordance with the Terms of Reference for the Pharmacology and Therapeutics Advisory Committee (PTAC) and PTAC Subcommittees 2008. Note: • • that this…
Schedule Update - effective 1 May 2012
(33 pages, 589 KB)
2012/04/18
“Q 300 Peptisoothe Arrow-Ranitidine Mycobutin Ropin ArrowRoxithromycin Asthalin Asthalin Duolin 2012 2012 2012 2014 2012 2014 2012 2012 2014 2012 2014 2014 2012 2014 2013 2013 2012 2012 2012 Apo-Selegiline”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May 2012 Section H cumulative for April and May 2012 Contents Summary of PHARMAC decisions effective 1 May 2012 ….. 3 Widening of access to dornase alfa … 4 Amendment…
